11/16/25 SymbioCellTech has been awarded the 2025 Levine-Riggs Symposium Scientific Achievement Award for its work on Neo-Islets as a therapy for Type 1 Diabetes Mellitus. Nov 18 Written by Travis Manning Travis Manning https://www.symbiocelltech.com Next Next SymbioCellTech’s Stem Cell-Enabled Therapy Could Offer a Functional Cure for Type 1 Diabetes Without Requiring Anti-Rejection Drugs
11/16/25 SymbioCellTech has been awarded the 2025 Levine-Riggs Symposium Scientific Achievement Award for its work on Neo-Islets as a therapy for Type 1 Diabetes Mellitus. Nov 18 Written by Travis Manning Travis Manning https://www.symbiocelltech.com
